BiotechTube
Home/Pipeline/Fortitude Kit 2.1

Fortitude Kit 2.1

SARS‑CoV‑2 & Influenza A/B detection

CommercialActive

Key Facts

Indication
SARS‑CoV‑2 & Influenza A/B detection
Phase
Commercial
Status
Active
Company
MiRXES

About MiRXES

RNA‑based diagnostics company delivering early‑cancer blood tests and NGS tissue profiling.

View full company profile

Therapeutic Areas

OncologyInfectious Diseases